Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation

NCT05005299 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Myeloid, Acute
Leukemia, Lymphoblastic, Acute, L1
Leukemia, Lymphoblastic, Acute, L2
Myelodysplastic Syndromes
Non-hodgkin Lymphoma
Plasma Cell Myeloma

Interventions

DRUG: Venetoclax
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

Melbourne Health